2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Membranous Nephropathy: new trials by email Literature Review of Membranous Nephropathy trials Research Report on Membranous Nephropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adrenocorticotropic Hormone in Membranous Nephropathy ACTHar - Membranous Nephropathy | Phase 4 | Completed | Icahn School of Medicine at Mount Sinai | 5 | 2018-03-19 | 2022-08-15 |
| To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN) TW - Membranous Nephropathy | Phase 4 | Completed | Nanjing University School of Medicine | 68 | 2007-07-01 | 2010-05-27 |
Glomerulonephritis, Membranous (2) · Proteinuria (2) · Glomerulonephritis (1)
Autoimmune Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Immune System Diseases (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Nephritis (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Urination Disorders (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Urological Manifestations (2) · Glomerulonephritis (1)
Adrenocorticotropic Hormone (1)
Icahn School of Medicine at Mount Sinai (1) · Nanjing University School of Medicine (1)
China (1) · United States (1)
Paolo Cravedi, MD, PhD (1) · Zhihong Liu, Master (1)